Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis
Background. An increase in aortic stiffness, as reflected by an increase in pulse wave velocity (PWV) or aortic augmentation index (AI) is an important predictor of cardiovascular mortality in dialysis patients. Dysregulation of calcification inhibitors, such as fetuin-A, is involved in vascular pat...
Gespeichert in:
| Veröffentlicht in: | Nephrology, dialysis, transplantation dialysis, transplantation, 2006-05, Vol.21 (5), p.1293-1299 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1299 |
|---|---|
| container_issue | 5 |
| container_start_page | 1293 |
| container_title | Nephrology, dialysis, transplantation |
| container_volume | 21 |
| creator | Hermans, Marc M. H. Brandenburg, Vincent Ketteler, Markus Kooman, Jeroen P. van der Sande, Frank M. Gladziwa, Ulrich Rensma, Pieter L. Bartelet, Karlijn Konings, Constantijn J. A. M. Hoeks, Arnold P. G. Floege, Jürgen Leunissen, Karel M. L. |
| description | Background. An increase in aortic stiffness, as reflected by an increase in pulse wave velocity (PWV) or aortic augmentation index (AI) is an important predictor of cardiovascular mortality in dialysis patients. Dysregulation of calcification inhibitors, such as fetuin-A, is involved in vascular pathology in dialysis patients and fetuin-A is inversely related to mortality in dialysis patients. In this study, the relation between serum fetuin-A concentration and parameters of aortic stiffness was investigated in patients with end-stage renal disease. Methods. In a cross-sectional study we included 131 dialysis patients, aged 62±14 years (33 on peritoneal dialysis and 98 on haemodialysis), and 41 controls, aged 60±8 years. Time-averaged pre-dialysis values of serum albumin, Ca, P and intact parathyroid hormone were included in multiregression analysis, as were high-sensitivity C-reactive protein (hsCRP), fetuin-A, age, mean arterial pressure (MAP) and dialysis modality. PWV and AI were measured with the SphygmoCor device. Results. Mean fetuin-A concentration in dialysis patients (0.63±0.16 g/l) did not differ from controls (0.63±0.11 g/l). Median hsCRP levels in dialysis patients were higher compared with controls (4.0 vs 1.9 mg/l; P |
| doi_str_mv | 10.1093/ndt/gfk045 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67885595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1028054341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-a785b1d3763e702f7b83e817c20ca3c114d1d875d08c6fcb3303412a3344e073</originalsourceid><addsrcrecordid>eNpd0EFrFDEUB_Agil1XL34ACYIehLEvk8kkcyzFWqEq1B6Kl5DNJN20s8mal8Hutzd1Fwue3uH9-PPen5DXDD4yGPhxHMvxjb-DTjwhC9b10LRciadkUZesAQHDEXmBeAsAQyvlc3LEej70g-QLcvOjzOOOpkjL2tHsJlNCirgOW5o8RZfnDfWuzCE2J9SmaF0s-a-hv0NZU5NyCZZiCd5Hh0hDpNu6rwwfUsdgph0GfEmeeTOhe3WYS3J19unq9Ly5-P75y-nJRWO5gtIYqcSKjVz23ElovVwp7hSTtgVruGWsG9mopBhB2d7bFefAO9YazrvOgeRL8n4fu83p1-yw6E1A66bJRJdm1L1USohBVPj2P3ib5hzrabplitVjZFvRhz2yOSFm5_U2h43JO81AP1Sva_V6X33Fbw6J82rjxkd66LqCdwdg0JrJZxNtwEcn69Oy_rMkzd4FLO7-397ku3o-l0KfX__UHL59vbyGS93xP1q6nDs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218138072</pqid></control><display><type>article</type><title>Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hermans, Marc M. H. ; Brandenburg, Vincent ; Ketteler, Markus ; Kooman, Jeroen P. ; van der Sande, Frank M. ; Gladziwa, Ulrich ; Rensma, Pieter L. ; Bartelet, Karlijn ; Konings, Constantijn J. A. M. ; Hoeks, Arnold P. G. ; Floege, Jürgen ; Leunissen, Karel M. L.</creator><creatorcontrib>Hermans, Marc M. H. ; Brandenburg, Vincent ; Ketteler, Markus ; Kooman, Jeroen P. ; van der Sande, Frank M. ; Gladziwa, Ulrich ; Rensma, Pieter L. ; Bartelet, Karlijn ; Konings, Constantijn J. A. M. ; Hoeks, Arnold P. G. ; Floege, Jürgen ; Leunissen, Karel M. L.</creatorcontrib><description>Background. An increase in aortic stiffness, as reflected by an increase in pulse wave velocity (PWV) or aortic augmentation index (AI) is an important predictor of cardiovascular mortality in dialysis patients. Dysregulation of calcification inhibitors, such as fetuin-A, is involved in vascular pathology in dialysis patients and fetuin-A is inversely related to mortality in dialysis patients. In this study, the relation between serum fetuin-A concentration and parameters of aortic stiffness was investigated in patients with end-stage renal disease. Methods. In a cross-sectional study we included 131 dialysis patients, aged 62±14 years (33 on peritoneal dialysis and 98 on haemodialysis), and 41 controls, aged 60±8 years. Time-averaged pre-dialysis values of serum albumin, Ca, P and intact parathyroid hormone were included in multiregression analysis, as were high-sensitivity C-reactive protein (hsCRP), fetuin-A, age, mean arterial pressure (MAP) and dialysis modality. PWV and AI were measured with the SphygmoCor device. Results. Mean fetuin-A concentration in dialysis patients (0.63±0.16 g/l) did not differ from controls (0.63±0.11 g/l). Median hsCRP levels in dialysis patients were higher compared with controls (4.0 vs 1.9 mg/l; P<0.0001). PWV but not AI was higher in dialysis patients than in controls (9.9 vs 7.9 m/s; P<0.0001). In univariate analysis in dialysis patients, fetuin-A levels were inversely related to both PWV (r = − 0.25, P = 0.007) and AI (r = − 0.26, P = 0.006), respectively. However, after correction for age, gender, MAP and diabetes mellitus, this relation lost statistical significance. Conclusions. In a dialysis population with a relatively low level of inflammatory activity, the soluble calcification inhibitor fetuin-A could not be identified as an independent predictor of aortic stiffness as measured with PWV and AI.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfk045</identifier><identifier>PMID: 16396973</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>alpha-Fetoproteins - metabolism ; Analysis of Variance ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Aortic Diseases - etiology ; Aortic Diseases - pathology ; arterial stiffness ; Biological and medical sciences ; Biomarkers - blood ; calcification ; Calcinosis - etiology ; Calcinosis - pathology ; Case-Control Studies ; Cross-Sectional Studies ; Disease Progression ; Emergency and intensive care: renal failure. Dialysis management ; end-stage renal disease ; Female ; Follow-Up Studies ; Glomerulonephritis ; Humans ; Intensive care medicine ; Kidney Failure, Chronic - diagnosis ; Kidney Failure, Chronic - therapy ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Predictive Value of Tests ; Pulsatile Flow ; pulse wave velocity ; Reference Values ; Renal Dialysis - adverse effects ; Renal Dialysis - methods ; Risk Factors ; Sensitivity and Specificity ; Severity of Illness Index ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Time Factors</subject><ispartof>Nephrology, dialysis, transplantation, 2006-05, Vol.21 (5), p.1293-1299</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) May 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-a785b1d3763e702f7b83e817c20ca3c114d1d875d08c6fcb3303412a3344e073</citedby><cites>FETCH-LOGICAL-c380t-a785b1d3763e702f7b83e817c20ca3c114d1d875d08c6fcb3303412a3344e073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17763730$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16396973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermans, Marc M. H.</creatorcontrib><creatorcontrib>Brandenburg, Vincent</creatorcontrib><creatorcontrib>Ketteler, Markus</creatorcontrib><creatorcontrib>Kooman, Jeroen P.</creatorcontrib><creatorcontrib>van der Sande, Frank M.</creatorcontrib><creatorcontrib>Gladziwa, Ulrich</creatorcontrib><creatorcontrib>Rensma, Pieter L.</creatorcontrib><creatorcontrib>Bartelet, Karlijn</creatorcontrib><creatorcontrib>Konings, Constantijn J. A. M.</creatorcontrib><creatorcontrib>Hoeks, Arnold P. G.</creatorcontrib><creatorcontrib>Floege, Jürgen</creatorcontrib><creatorcontrib>Leunissen, Karel M. L.</creatorcontrib><title>Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. An increase in aortic stiffness, as reflected by an increase in pulse wave velocity (PWV) or aortic augmentation index (AI) is an important predictor of cardiovascular mortality in dialysis patients. Dysregulation of calcification inhibitors, such as fetuin-A, is involved in vascular pathology in dialysis patients and fetuin-A is inversely related to mortality in dialysis patients. In this study, the relation between serum fetuin-A concentration and parameters of aortic stiffness was investigated in patients with end-stage renal disease. Methods. In a cross-sectional study we included 131 dialysis patients, aged 62±14 years (33 on peritoneal dialysis and 98 on haemodialysis), and 41 controls, aged 60±8 years. Time-averaged pre-dialysis values of serum albumin, Ca, P and intact parathyroid hormone were included in multiregression analysis, as were high-sensitivity C-reactive protein (hsCRP), fetuin-A, age, mean arterial pressure (MAP) and dialysis modality. PWV and AI were measured with the SphygmoCor device. Results. Mean fetuin-A concentration in dialysis patients (0.63±0.16 g/l) did not differ from controls (0.63±0.11 g/l). Median hsCRP levels in dialysis patients were higher compared with controls (4.0 vs 1.9 mg/l; P<0.0001). PWV but not AI was higher in dialysis patients than in controls (9.9 vs 7.9 m/s; P<0.0001). In univariate analysis in dialysis patients, fetuin-A levels were inversely related to both PWV (r = − 0.25, P = 0.007) and AI (r = − 0.26, P = 0.006), respectively. However, after correction for age, gender, MAP and diabetes mellitus, this relation lost statistical significance. Conclusions. In a dialysis population with a relatively low level of inflammatory activity, the soluble calcification inhibitor fetuin-A could not be identified as an independent predictor of aortic stiffness as measured with PWV and AI.</description><subject>alpha-Fetoproteins - metabolism</subject><subject>Analysis of Variance</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Aortic Diseases - etiology</subject><subject>Aortic Diseases - pathology</subject><subject>arterial stiffness</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>calcification</subject><subject>Calcinosis - etiology</subject><subject>Calcinosis - pathology</subject><subject>Case-Control Studies</subject><subject>Cross-Sectional Studies</subject><subject>Disease Progression</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>end-stage renal disease</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glomerulonephritis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - diagnosis</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Predictive Value of Tests</subject><subject>Pulsatile Flow</subject><subject>pulse wave velocity</subject><subject>Reference Values</subject><subject>Renal Dialysis - adverse effects</subject><subject>Renal Dialysis - methods</subject><subject>Risk Factors</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Time Factors</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0EFrFDEUB_Agil1XL34ACYIehLEvk8kkcyzFWqEq1B6Kl5DNJN20s8mal8Hutzd1Fwue3uH9-PPen5DXDD4yGPhxHMvxjb-DTjwhC9b10LRciadkUZesAQHDEXmBeAsAQyvlc3LEej70g-QLcvOjzOOOpkjL2tHsJlNCirgOW5o8RZfnDfWuzCE2J9SmaF0s-a-hv0NZU5NyCZZiCd5Hh0hDpNu6rwwfUsdgph0GfEmeeTOhe3WYS3J19unq9Ly5-P75y-nJRWO5gtIYqcSKjVz23ElovVwp7hSTtgVruGWsG9mopBhB2d7bFefAO9YazrvOgeRL8n4fu83p1-yw6E1A66bJRJdm1L1USohBVPj2P3ib5hzrabplitVjZFvRhz2yOSFm5_U2h43JO81AP1Sva_V6X33Fbw6J82rjxkd66LqCdwdg0JrJZxNtwEcn69Oy_rMkzd4FLO7-397ku3o-l0KfX__UHL59vbyGS93xP1q6nDs</recordid><startdate>20060501</startdate><enddate>20060501</enddate><creator>Hermans, Marc M. H.</creator><creator>Brandenburg, Vincent</creator><creator>Ketteler, Markus</creator><creator>Kooman, Jeroen P.</creator><creator>van der Sande, Frank M.</creator><creator>Gladziwa, Ulrich</creator><creator>Rensma, Pieter L.</creator><creator>Bartelet, Karlijn</creator><creator>Konings, Constantijn J. A. M.</creator><creator>Hoeks, Arnold P. G.</creator><creator>Floege, Jürgen</creator><creator>Leunissen, Karel M. L.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20060501</creationdate><title>Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis</title><author>Hermans, Marc M. H. ; Brandenburg, Vincent ; Ketteler, Markus ; Kooman, Jeroen P. ; van der Sande, Frank M. ; Gladziwa, Ulrich ; Rensma, Pieter L. ; Bartelet, Karlijn ; Konings, Constantijn J. A. M. ; Hoeks, Arnold P. G. ; Floege, Jürgen ; Leunissen, Karel M. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-a785b1d3763e702f7b83e817c20ca3c114d1d875d08c6fcb3303412a3344e073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>alpha-Fetoproteins - metabolism</topic><topic>Analysis of Variance</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Aortic Diseases - etiology</topic><topic>Aortic Diseases - pathology</topic><topic>arterial stiffness</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>calcification</topic><topic>Calcinosis - etiology</topic><topic>Calcinosis - pathology</topic><topic>Case-Control Studies</topic><topic>Cross-Sectional Studies</topic><topic>Disease Progression</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>end-stage renal disease</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glomerulonephritis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - diagnosis</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Predictive Value of Tests</topic><topic>Pulsatile Flow</topic><topic>pulse wave velocity</topic><topic>Reference Values</topic><topic>Renal Dialysis - adverse effects</topic><topic>Renal Dialysis - methods</topic><topic>Risk Factors</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermans, Marc M. H.</creatorcontrib><creatorcontrib>Brandenburg, Vincent</creatorcontrib><creatorcontrib>Ketteler, Markus</creatorcontrib><creatorcontrib>Kooman, Jeroen P.</creatorcontrib><creatorcontrib>van der Sande, Frank M.</creatorcontrib><creatorcontrib>Gladziwa, Ulrich</creatorcontrib><creatorcontrib>Rensma, Pieter L.</creatorcontrib><creatorcontrib>Bartelet, Karlijn</creatorcontrib><creatorcontrib>Konings, Constantijn J. A. M.</creatorcontrib><creatorcontrib>Hoeks, Arnold P. G.</creatorcontrib><creatorcontrib>Floege, Jürgen</creatorcontrib><creatorcontrib>Leunissen, Karel M. L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermans, Marc M. H.</au><au>Brandenburg, Vincent</au><au>Ketteler, Markus</au><au>Kooman, Jeroen P.</au><au>van der Sande, Frank M.</au><au>Gladziwa, Ulrich</au><au>Rensma, Pieter L.</au><au>Bartelet, Karlijn</au><au>Konings, Constantijn J. A. M.</au><au>Hoeks, Arnold P. G.</au><au>Floege, Jürgen</au><au>Leunissen, Karel M. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2006-05-01</date><risdate>2006</risdate><volume>21</volume><issue>5</issue><spage>1293</spage><epage>1299</epage><pages>1293-1299</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. An increase in aortic stiffness, as reflected by an increase in pulse wave velocity (PWV) or aortic augmentation index (AI) is an important predictor of cardiovascular mortality in dialysis patients. Dysregulation of calcification inhibitors, such as fetuin-A, is involved in vascular pathology in dialysis patients and fetuin-A is inversely related to mortality in dialysis patients. In this study, the relation between serum fetuin-A concentration and parameters of aortic stiffness was investigated in patients with end-stage renal disease. Methods. In a cross-sectional study we included 131 dialysis patients, aged 62±14 years (33 on peritoneal dialysis and 98 on haemodialysis), and 41 controls, aged 60±8 years. Time-averaged pre-dialysis values of serum albumin, Ca, P and intact parathyroid hormone were included in multiregression analysis, as were high-sensitivity C-reactive protein (hsCRP), fetuin-A, age, mean arterial pressure (MAP) and dialysis modality. PWV and AI were measured with the SphygmoCor device. Results. Mean fetuin-A concentration in dialysis patients (0.63±0.16 g/l) did not differ from controls (0.63±0.11 g/l). Median hsCRP levels in dialysis patients were higher compared with controls (4.0 vs 1.9 mg/l; P<0.0001). PWV but not AI was higher in dialysis patients than in controls (9.9 vs 7.9 m/s; P<0.0001). In univariate analysis in dialysis patients, fetuin-A levels were inversely related to both PWV (r = − 0.25, P = 0.007) and AI (r = − 0.26, P = 0.006), respectively. However, after correction for age, gender, MAP and diabetes mellitus, this relation lost statistical significance. Conclusions. In a dialysis population with a relatively low level of inflammatory activity, the soluble calcification inhibitor fetuin-A could not be identified as an independent predictor of aortic stiffness as measured with PWV and AI.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16396973</pmid><doi>10.1093/ndt/gfk045</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0931-0509 |
| ispartof | Nephrology, dialysis, transplantation, 2006-05, Vol.21 (5), p.1293-1299 |
| issn | 0931-0509 1460-2385 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67885595 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | alpha-Fetoproteins - metabolism Analysis of Variance Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Aortic Diseases - etiology Aortic Diseases - pathology arterial stiffness Biological and medical sciences Biomarkers - blood calcification Calcinosis - etiology Calcinosis - pathology Case-Control Studies Cross-Sectional Studies Disease Progression Emergency and intensive care: renal failure. Dialysis management end-stage renal disease Female Follow-Up Studies Glomerulonephritis Humans Intensive care medicine Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - therapy Male Medical sciences Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Predictive Value of Tests Pulsatile Flow pulse wave velocity Reference Values Renal Dialysis - adverse effects Renal Dialysis - methods Risk Factors Sensitivity and Specificity Severity of Illness Index Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Time Factors |
| title | Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A25%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20on%20the%20relationship%20of%20serum%20fetuin-A%20concentration%20with%20aortic%20stiffness%20in%20patients%20on%20dialysis&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Hermans,%20Marc%20M.%20H.&rft.date=2006-05-01&rft.volume=21&rft.issue=5&rft.spage=1293&rft.epage=1299&rft.pages=1293-1299&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfk045&rft_dat=%3Cproquest_cross%3E1028054341%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218138072&rft_id=info:pmid/16396973&rfr_iscdi=true |